Homepage
AI-ready clinical data infrastructure for pharma, biotech, frontier AI labs, RWE teams, CROs, and health systems. 12.3M patients, five linked modalities, OMOP CDM normalized.

OmicsBank builds clinical data infrastructure that standardizes hospital multimodal records for research and healthcare AI.
omicsbank.comCrawled Sep 27, 2026
AI-ready clinical data infrastructure for pharma, biotech, frontier AI labs, RWE teams, CROs, and health systems. 12.3M patients, five linked modalities, OMOP CDM normalized.
OmicsBank raises a $2.25 million seed round led by Redesign Health, with a plan to license Asian and U.S. patient data to biopharma companies. The company is positioning those datasets for use in AI-driven drug discovery.
OmicsBank raises $2.25 million in seed funding from Redesign Health to expand its clinical data infrastructure across the United States, Asia, and the Middle East. The company says its clinical data network reaches 12.5 million patients and more than 90 hospitals.
OmicsBank raises $2.25 million in seed funding from Redesign Health to expand U.S. clinical data infrastructure. The company also plans to broaden access to multimodal patient data from Asia and the Middle East. Its infrastructure serves healthcare, life sciences, and frontier AI labs.
OmicsBank secures $2.25 million in seed funding from Redesign Health to expand its clinical data infrastructure. The expansion spans the U.S., Asia, and the Middle East, with drug development and healthcare AI identified as intended applications.
OmicsBank, a clinical data infrastructure company, raises $2.25 million in seed funding from Redesign Health to scale global multi-omics data infrastructure. It connects fragmented hospital archives for biopharma and frontier AI developers.